

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.69365264 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 7.48347815 |
| 3 | angiotensin maturation (GO:0002003) | 7.41680944 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 7.16805867 |
| 5 | drug catabolic process (GO:0042737) | 7.01738048 |
| 6 | drug transmembrane transport (GO:0006855) | 6.55001204 |
| 7 | actin filament depolymerization (GO:0030042) | 6.08718948 |
| 8 | drug transport (GO:0015893) | 5.98569383 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 5.83147638 |
| 10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.63465056 |
| 11 | exogenous drug catabolic process (GO:0042738) | 5.37213971 |
| 12 | urate metabolic process (GO:0046415) | 5.32327002 |
| 13 | renal absorption (GO:0070293) | 5.22070818 |
| 14 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.18930725 |
| 15 | modified amino acid transport (GO:0072337) | 5.16713001 |
| 16 | flavonoid metabolic process (GO:0009812) | 5.15557736 |
| 17 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.10652142 |
| 18 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.05442118 |
| 19 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.03124815 |
| 20 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.03124815 |
| 21 | endocrine process (GO:0050886) | 5.03124815 |
| 22 | regulation of bile acid biosynthetic process (GO:0070857) | 4.79806704 |
| 23 | plasma lipoprotein particle assembly (GO:0034377) | 4.69266911 |
| 24 | regulation of systemic arterial blood pressure (GO:0003073) | 4.60943517 |
| 25 | NADH metabolic process (GO:0006734) | 4.56940755 |
| 26 | vitamin A metabolic process (GO:0006776) | 4.54105122 |
| 27 | polyol transport (GO:0015791) | 4.48673612 |
| 28 | lysine catabolic process (GO:0006554) | 4.48454913 |
| 29 | lysine metabolic process (GO:0006553) | 4.48454913 |
| 30 | peptide catabolic process (GO:0043171) | 4.43566546 |
| 31 | oligosaccharide catabolic process (GO:0009313) | 4.43102818 |
| 32 | excretion (GO:0007588) | 4.42646224 |
| 33 | protein-lipid complex assembly (GO:0065005) | 4.40613613 |
| 34 | positive regulation of pseudopodium assembly (GO:0031274) | 4.38677322 |
| 35 | phosphate ion transport (GO:0006817) | 4.35866978 |
| 36 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.32464312 |
| 37 | urea cycle (GO:0000050) | 4.31243711 |
| 38 | renal system process involved in regulation of blood volume (GO:0001977) | 4.29074307 |
| 39 | regulation of cGMP biosynthetic process (GO:0030826) | 4.28086069 |
| 40 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.27245424 |
| 41 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.26943888 |
| 42 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.25564908 |
| 43 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.23096267 |
| 44 | regulation of cellular extravasation (GO:0002691) | 4.22783484 |
| 45 | sulfur compound transport (GO:0072348) | 4.22735811 |
| 46 | digestive system process (GO:0022600) | 4.21857472 |
| 47 | transepithelial transport (GO:0070633) | 4.20683576 |
| 48 | urea metabolic process (GO:0019627) | 4.18295815 |
| 49 | sulfate transmembrane transport (GO:1902358) | 4.17715994 |
| 50 | organic cation transport (GO:0015695) | 4.15851442 |
| 51 | virion attachment to host cell (GO:0019062) | 4.13915680 |
| 52 | adhesion of symbiont to host cell (GO:0044650) | 4.13915680 |
| 53 | regulation of cholesterol esterification (GO:0010872) | 4.10399892 |
| 54 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.10045822 |
| 55 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.10045822 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 4.09240391 |
| 57 | glucose 6-phosphate metabolic process (GO:0051156) | 4.09132677 |
| 58 | homocysteine metabolic process (GO:0050667) | 4.08276030 |
| 59 | hormone catabolic process (GO:0042447) | 3.98676182 |
| 60 | regulation of cholesterol homeostasis (GO:2000188) | 3.97792147 |
| 61 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.93383779 |
| 62 | bicarbonate transport (GO:0015701) | 3.92027130 |
| 63 | cysteine metabolic process (GO:0006534) | 3.90485774 |
| 64 | regulation of pseudopodium assembly (GO:0031272) | 3.89987957 |
| 65 | phosphate ion transmembrane transport (GO:0035435) | 3.86728451 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 3.85664493 |
| 67 | membrane repolarization during action potential (GO:0086011) | 3.83517043 |
| 68 | glutathione biosynthetic process (GO:0006750) | 3.83179315 |
| 69 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.79672114 |
| 70 | phospholipid efflux (GO:0033700) | 3.77954582 |
| 71 | antibacterial humoral response (GO:0019731) | 3.74897460 |
| 72 | vitamin transmembrane transport (GO:0035461) | 3.71063267 |
| 73 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.69566247 |
| 74 | digestion (GO:0007586) | 3.68838193 |
| 75 | fructose metabolic process (GO:0006000) | 3.68825137 |
| 76 | response to hepatocyte growth factor (GO:0035728) | 3.65402852 |
| 77 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.65402852 |
| 78 | antimicrobial humoral response (GO:0019730) | 3.64703839 |
| 79 | GDP-mannose metabolic process (GO:0019673) | 3.61465048 |
| 80 | quaternary ammonium group transport (GO:0015697) | 3.60926456 |
| 81 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.60242276 |
| 82 | response to mercury ion (GO:0046689) | 3.58368318 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.57909408 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.57909408 |
| 85 | positive regulation of digestive system process (GO:0060456) | 3.54715728 |
| 86 | intestinal epithelial cell development (GO:0060576) | 3.53016275 |
| 87 | proline metabolic process (GO:0006560) | 3.52085157 |
| 88 | disruption of cells of other organism (GO:0044364) | 3.49916342 |
| 89 | killing of cells of other organism (GO:0031640) | 3.49916342 |
| 90 | phosphate ion homeostasis (GO:0055062) | 3.49772476 |
| 91 | trivalent inorganic anion homeostasis (GO:0072506) | 3.49772476 |
| 92 | cGMP-mediated signaling (GO:0019934) | 3.49387875 |
| 93 | regulation of cGMP metabolic process (GO:0030823) | 3.49151070 |
| 94 | lipoprotein metabolic process (GO:0042157) | 3.45292976 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.44968886 |
| 96 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.44472046 |
| 97 | drug metabolic process (GO:0017144) | 3.42949119 |
| 98 | regulation of vitamin metabolic process (GO:0030656) | 3.42776865 |
| 99 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.42205765 |
| 100 | cytidine deamination (GO:0009972) | 3.40511542 |
| 101 | cytidine metabolic process (GO:0046087) | 3.40511542 |
| 102 | cytidine catabolic process (GO:0006216) | 3.40511542 |
| 103 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.40341439 |
| 104 | sulfate transport (GO:0008272) | 3.39872169 |
| 105 | plasma lipoprotein particle organization (GO:0071827) | 3.39495790 |
| 106 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.37554360 |
| 107 | cellular carbohydrate catabolic process (GO:0044275) | 3.34653555 |
| 108 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.33305667 |
| 109 | high-density lipoprotein particle remodeling (GO:0034375) | 3.33266208 |
| 110 | drinking behavior (GO:0042756) | 3.32593836 |
| 111 | defense response to fungus (GO:0050832) | 3.31780351 |
| 112 | protein-lipid complex subunit organization (GO:0071825) | 3.31731634 |
| 113 | peptide biosynthetic process (GO:0043043) | 3.31008878 |
| 114 | protein-lipid complex remodeling (GO:0034368) | 3.30151640 |
| 115 | macromolecular complex remodeling (GO:0034367) | 3.30151640 |
| 116 | plasma lipoprotein particle remodeling (GO:0034369) | 3.30151640 |
| 117 | negative regulation of digestive system process (GO:0060457) | 3.30052066 |
| 118 | positive regulation of respiratory burst (GO:0060267) | 3.29660150 |
| 119 | glutathione derivative metabolic process (GO:1901685) | 3.29542994 |
| 120 | glutathione derivative biosynthetic process (GO:1901687) | 3.29542994 |
| 121 | vitamin D metabolic process (GO:0042359) | 3.28330696 |
| 122 | cellular response to nitric oxide (GO:0071732) | 3.24993983 |
| 123 | glycosphingolipid catabolic process (GO:0046479) | 3.24207641 |
| 124 | regulation of digestive system process (GO:0044058) | 3.23907189 |
| 125 | diacylglycerol metabolic process (GO:0046339) | 3.22521313 |
| 126 | glycolipid catabolic process (GO:0019377) | 3.22172818 |
| 127 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.21843638 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 3.19901947 |
| 129 | regulation of respiratory burst (GO:0060263) | 3.18998491 |
| 130 | arginine metabolic process (GO:0006525) | 3.18326160 |
| 131 | alkaloid metabolic process (GO:0009820) | 3.17165184 |
| 132 | vitamin transport (GO:0051180) | 3.16909773 |
| 133 | adhesion of symbiont to host (GO:0044406) | 3.15754627 |
| 134 | bile acid and bile salt transport (GO:0015721) | 3.15686676 |
| 135 | transcytosis (GO:0045056) | 3.12355298 |
| 136 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.10958104 |
| 137 | desmosome organization (GO:0002934) | 3.10837855 |
| 138 | regulation of cholesterol metabolic process (GO:0090181) | 3.08245850 |
| 139 | cellular response to vitamin D (GO:0071305) | 3.08006190 |
| 140 | low-density lipoprotein particle remodeling (GO:0034374) | 3.06948750 |
| 141 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.06207536 |
| 142 | auditory receptor cell differentiation (GO:0042491) | 3.05525875 |
| 143 | glyoxylate metabolic process (GO:0046487) | 3.05170132 |
| 144 | proline biosynthetic process (GO:0006561) | 3.03899471 |
| 145 | response to phenylpropanoid (GO:0080184) | 3.03365667 |
| 146 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.01790613 |
| 147 | O-glycan processing (GO:0016266) | 3.00994331 |
| 148 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.00394504 |
| 149 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.00394504 |
| 150 | response to nitric oxide (GO:0071731) | 2.99284100 |
| 151 | ethanol oxidation (GO:0006069) | 2.98608020 |
| 152 | carnitine transport (GO:0015879) | 2.98362578 |
| 153 | amino-acid betaine transport (GO:0015838) | 2.98362578 |
| 154 | sterol homeostasis (GO:0055092) | 2.97612679 |
| 155 | negative regulation of cholesterol transport (GO:0032375) | 2.96937220 |
| 156 | negative regulation of sterol transport (GO:0032372) | 2.96937220 |
| 157 | tricarboxylic acid metabolic process (GO:0072350) | 2.96896135 |
| 158 | regulation of extracellular matrix disassembly (GO:0010715) | 2.96699852 |
| 159 | peptide hormone processing (GO:0016486) | 2.96246561 |
| 160 | phospholipid scrambling (GO:0017121) | 2.95503402 |
| 161 | cellular glucuronidation (GO:0052695) | 2.94809476 |
| 162 | lipoprotein transport (GO:0042953) | 2.93599427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.62459481 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.45790916 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.77287343 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.71824670 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.68828162 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.44968234 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.28661320 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.21405229 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.05618301 |
| 10 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.96360827 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84142193 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.76089042 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.72590480 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.64024794 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.52894491 |
| 16 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.49438380 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.41358979 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.23928703 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.15656561 |
| 20 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.05124241 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04345151 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96976585 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.93586178 |
| 24 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.90006565 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.87576301 |
| 26 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.87320176 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80548513 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.78432316 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.76578409 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75673979 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.73800469 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.72496173 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70078023 |
| 34 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.66809182 |
| 35 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.63401358 |
| 36 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.62435385 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60735327 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.60060472 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.57454369 |
| 40 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.57010540 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56307687 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55703300 |
| 43 | ATF3_27146783_Chip-Seq_COLON_Human | 1.52609784 |
| 44 | SA1_27219007_Chip-Seq_Bcells_Human | 1.52506997 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52349686 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52206652 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50281169 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47242177 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.46159972 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45739930 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42647095 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41144483 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40517482 |
| 54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37132556 |
| 55 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.36432823 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32780842 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31507434 |
| 58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30816794 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29447789 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28652097 |
| 61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28604989 |
| 62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.25484668 |
| 63 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.24551044 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24200922 |
| 65 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20260350 |
| 66 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17800209 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17206700 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16570983 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15363011 |
| 70 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.15035077 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15011219 |
| 72 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14840216 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14227004 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13613357 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12665393 |
| 76 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12307427 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11834231 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11512800 |
| 79 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10051491 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10008351 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.09905112 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09185464 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08957500 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07289801 |
| 85 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06666217 |
| 86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06390089 |
| 87 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05303382 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02674149 |
| 89 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02542376 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02212573 |
| 91 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01954167 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01944566 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01765141 |
| 94 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00850017 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00765740 |
| 96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00394944 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00208159 |
| 98 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.99082546 |
| 99 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.98408555 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98029909 |
| 101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98008083 |
| 102 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96751979 |
| 103 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.95636820 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94408427 |
| 105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94343336 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93651024 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93326420 |
| 108 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.92998676 |
| 109 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92407047 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90876523 |
| 111 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90836761 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90470550 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90334361 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89855670 |
| 115 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87829233 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87277323 |
| 117 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.87233546 |
| 118 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86869832 |
| 119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86543602 |
| 120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84416463 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84415014 |
| 122 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84133743 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83896441 |
| 124 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81442078 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81208052 |
| 126 | P68_20966046_ChIP-Seq_HELA_Human | 0.80409080 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79061344 |
| 128 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.78929437 |
| 129 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78552279 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.77390616 |
| 131 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76881312 |
| 132 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76347369 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75898512 |
| 134 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.75278501 |
| 135 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74376985 |
| 136 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73844266 |
| 137 | GATA1_22025678_ChIP-Seq_K562_Human | 0.73721813 |
| 138 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.72558208 |
| 139 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.72119208 |
| 140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.71587287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.19964424 |
| 2 | MP0001666_abnormal_nutrient_absorption | 4.49588590 |
| 3 | MP0004043_abnormal_pH_regulation | 4.43430481 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.32414686 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.89355910 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.39806233 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.19990850 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.11145111 |
| 9 | MP0003252_abnormal_bile_duct | 2.86639698 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.83955453 |
| 11 | MP0005332_abnormal_amino_acid | 2.78145653 |
| 12 | MP0000462_abnormal_digestive_system | 2.67985566 |
| 13 | MP0009643_abnormal_urine_homeostasis | 2.63918809 |
| 14 | MP0003878_abnormal_ear_physiology | 2.62155667 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.62155667 |
| 16 | MP0005409_darkened_coat_color | 2.52977677 |
| 17 | MP0001765_abnormal_ion_homeostasis | 2.45847402 |
| 18 | MP0003866_abnormal_defecation | 2.42231254 |
| 19 | MP0005365_abnormal_bile_salt | 2.21164523 |
| 20 | MP0000538_abnormal_urinary_bladder | 2.12246939 |
| 21 | MP0001756_abnormal_urination | 2.08268244 |
| 22 | MP0009840_abnormal_foam_cell | 2.07193172 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.02667743 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 1.91395964 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.87447571 |
| 26 | MP0001663_abnormal_digestive_system | 1.86373223 |
| 27 | MP0005670_abnormal_white_adipose | 1.85020752 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.82466521 |
| 29 | MP0002136_abnormal_kidney_physiology | 1.78398215 |
| 30 | MP0005381_digestive/alimentary_phenotyp | 1.76604976 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.73068092 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.71862882 |
| 33 | MP0000537_abnormal_urethra_morphology | 1.69478704 |
| 34 | MP0001664_abnormal_digestion | 1.68812416 |
| 35 | MP0004858_abnormal_nervous_system | 1.66796481 |
| 36 | MP0002822_catalepsy | 1.60638521 |
| 37 | MP0001873_stomach_inflammation | 1.54992387 |
| 38 | MP0004147_increased_porphyrin_level | 1.54522438 |
| 39 | MP0003195_calcinosis | 1.51488956 |
| 40 | MP0001188_hyperpigmentation | 1.45088937 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.44400969 |
| 42 | MP0000490_abnormal_crypts_of | 1.42744680 |
| 43 | MP0002796_impaired_skin_barrier | 1.39714794 |
| 44 | MP0000477_abnormal_intestine_morphology | 1.35264325 |
| 45 | MP0009379_abnormal_foot_pigmentation | 1.33578983 |
| 46 | MP0005451_abnormal_body_composition | 1.32181852 |
| 47 | MP0000566_synostosis | 1.29834410 |
| 48 | MP0002089_abnormal_postnatal_growth/wei | 1.25854500 |
| 49 | MP0008004_abnormal_stomach_pH | 1.23661571 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.22229398 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.22078374 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.15117188 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.15058224 |
| 54 | MP0003283_abnormal_digestive_organ | 1.11299756 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.10973413 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.07544043 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 0.96615991 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.96346448 |
| 59 | MP0008872_abnormal_physiological_respon | 0.96094546 |
| 60 | MP0005501_abnormal_skin_physiology | 0.94785214 |
| 61 | MP0001485_abnormal_pinna_reflex | 0.93082302 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 0.92669209 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 0.90374024 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90306365 |
| 65 | MP0003315_abnormal_perineum_morphology | 0.89383612 |
| 66 | MP0000678_abnormal_parathyroid_gland | 0.87114156 |
| 67 | MP0002098_abnormal_vibrissa_morphology | 0.87042446 |
| 68 | MP0001764_abnormal_homeostasis | 0.86358482 |
| 69 | MP0001849_ear_inflammation | 0.85372016 |
| 70 | MP0003879_abnormal_hair_cell | 0.83770734 |
| 71 | MP0006054_spinal_hemorrhage | 0.83536787 |
| 72 | MP0008260_abnormal_autophagy | 0.81935900 |
| 73 | MP0002971_abnormal_brown_adipose | 0.81692578 |
| 74 | MP0000230_abnormal_systemic_arterial | 0.81055316 |
| 75 | MP0005448_abnormal_energy_balance | 0.78343876 |
| 76 | MP0000609_abnormal_liver_physiology | 0.75781566 |
| 77 | MP0004885_abnormal_endolymph | 0.70260068 |
| 78 | MP0005535_abnormal_body_temperature | 0.68342087 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.68146620 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.66645006 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.64319303 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.64292802 |
| 83 | MP0009115_abnormal_fat_cell | 0.63828949 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.63708903 |
| 85 | MP0001501_abnormal_sleep_pattern | 0.62208513 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.61800049 |
| 87 | MP0005166_decreased_susceptibility_to | 0.61306927 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.60397522 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.60299622 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.59046579 |
| 91 | MP0010678_abnormal_skin_adnexa | 0.58051105 |
| 92 | MP0003329_amyloid_beta_deposits | 0.57774506 |
| 93 | MP0000467_abnormal_esophagus_morphology | 0.57735500 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.57435832 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.57233316 |
| 96 | MP0000249_abnormal_blood_vessel | 0.57035838 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.56020230 |
| 98 | MP0003718_maternal_effect | 0.54822047 |
| 99 | MP0005083_abnormal_biliary_tract | 0.53900469 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.53087730 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.52722394 |
| 102 | MP0002135_abnormal_kidney_morphology | 0.51954932 |
| 103 | MP0008469_abnormal_protein_level | 0.51923607 |
| 104 | MP0003868_abnormal_feces_composition | 0.49891036 |
| 105 | MP0009053_abnormal_anal_canal | 0.49452447 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.48834926 |
| 107 | MP0004484_altered_response_of | 0.48337929 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.47323282 |
| 109 | MP0003693_abnormal_embryo_hatching | 0.46908744 |
| 110 | MP0000604_amyloidosis | 0.46810239 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.46579406 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.46433419 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.45966033 |
| 114 | MP0005334_abnormal_fat_pad | 0.45607087 |
| 115 | MP0005310_abnormal_salivary_gland | 0.45587470 |
| 116 | MP0000613_abnormal_salivary_gland | 0.45263309 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.44622270 |
| 118 | MP0002254_reproductive_system_inflammat | 0.44553228 |
| 119 | MP0000470_abnormal_stomach_morphology | 0.41489230 |
| 120 | MP0004947_skin_inflammation | 0.40301616 |
| 121 | MP0003953_abnormal_hormone_level | 0.39646897 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.38889786 |
| 123 | MP0009780_abnormal_chondrocyte_physiolo | 0.38169434 |
| 124 | MP0001191_abnormal_skin_condition | 0.37113524 |
| 125 | MP0001958_emphysema | 0.35390582 |
| 126 | MP0003941_abnormal_skin_development | 0.33901115 |
| 127 | MP0004270_analgesia | 0.33616614 |
| 128 | MP0000377_abnormal_hair_follicle | 0.33508649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 7.00005571 |
| 2 | Abnormality of chloride homeostasis (HP:0011422) | 6.45433442 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 6.38539727 |
| 4 | Ileus (HP:0002595) | 5.99770607 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.92998926 |
| 6 | Increased circulating renin level (HP:0000848) | 5.50907782 |
| 7 | Hypokalemic alkalosis (HP:0001949) | 5.28693424 |
| 8 | Malnutrition (HP:0004395) | 4.88236194 |
| 9 | Abnormal urine output (HP:0012590) | 4.85155301 |
| 10 | Hypomagnesemia (HP:0002917) | 4.70031847 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 4.58645032 |
| 12 | Abnormality of renal excretion (HP:0011036) | 4.57426362 |
| 13 | Polyuria (HP:0000103) | 4.49259982 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.43751948 |
| 15 | Gout (HP:0001997) | 4.25090630 |
| 16 | Alkalosis (HP:0001948) | 4.20884880 |
| 17 | Hyperaldosteronism (HP:0000859) | 4.20216755 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 4.18254304 |
| 19 | Hyperglycinuria (HP:0003108) | 4.16977665 |
| 20 | Proximal tubulopathy (HP:0000114) | 4.14938755 |
| 21 | Glycosuria (HP:0003076) | 4.00888026 |
| 22 | Abnormality of urine glucose concentration (HP:0011016) | 4.00888026 |
| 23 | Abnormality of proline metabolism (HP:0010907) | 3.94990961 |
| 24 | Hydroxyprolinuria (HP:0003080) | 3.94990961 |
| 25 | Xanthomatosis (HP:0000991) | 3.91690134 |
| 26 | Abnormality of purine metabolism (HP:0004352) | 3.69163879 |
| 27 | Widely patent fontanelles and sutures (HP:0004492) | 3.63496501 |
| 28 | Hemorrhage of the eye (HP:0011885) | 3.59587587 |
| 29 | Tetany (HP:0001281) | 3.53521746 |
| 30 | Increased purine levels (HP:0004368) | 3.53258624 |
| 31 | Hyperuricemia (HP:0002149) | 3.53258624 |
| 32 | Dehydration (HP:0001944) | 3.49255136 |
| 33 | Hypercalciuria (HP:0002150) | 3.47556192 |
| 34 | Renal salt wasting (HP:0000127) | 3.43525856 |
| 35 | Hyperphosphaturia (HP:0003109) | 3.42876312 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 3.33089661 |
| 37 | Polydipsia (HP:0001959) | 3.32168383 |
| 38 | Abnormal drinking behavior (HP:0030082) | 3.32168383 |
| 39 | Hypokalemia (HP:0002900) | 3.26304746 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.16828263 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.16828263 |
| 42 | Abnormal urine phosphate concentration (HP:0012599) | 3.11916408 |
| 43 | Focal segmental glomerulosclerosis (HP:0000097) | 3.11900794 |
| 44 | Congenital sensorineural hearing impairment (HP:0008527) | 3.11602866 |
| 45 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.99487659 |
| 46 | Acanthocytosis (HP:0001927) | 2.96276326 |
| 47 | Delayed epiphyseal ossification (HP:0002663) | 2.94517612 |
| 48 | Nephrolithiasis (HP:0000787) | 2.91830893 |
| 49 | Ketoacidosis (HP:0001993) | 2.89492121 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 2.86851135 |
| 51 | Facial shape deformation (HP:0011334) | 2.86272373 |
| 52 | Potter facies (HP:0002009) | 2.86272373 |
| 53 | Abnormality of vitamin B metabolism (HP:0004340) | 2.84635245 |
| 54 | Abdominal distention (HP:0003270) | 2.77716323 |
| 55 | Glomerulonephritis (HP:0000099) | 2.77614977 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.70445854 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.68969842 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.68578744 |
| 59 | Abnormality of potassium homeostasis (HP:0011042) | 2.67976733 |
| 60 | Abnormal tarsal ossification (HP:0008369) | 2.66732983 |
| 61 | Hyperparathyroidism (HP:0000843) | 2.63487104 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.59510175 |
| 63 | Hypobetalipoproteinemia (HP:0003563) | 2.59321583 |
| 64 | Abnormality of complement system (HP:0005339) | 2.56174117 |
| 65 | Complement deficiency (HP:0004431) | 2.54631294 |
| 66 | Thin bony cortex (HP:0002753) | 2.54062509 |
| 67 | Confusion (HP:0001289) | 2.51246226 |
| 68 | Hypophosphatemia (HP:0002148) | 2.49730378 |
| 69 | Glomerulosclerosis (HP:0000096) | 2.47296337 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.43486547 |
| 71 | Wide cranial sutures (HP:0010537) | 2.41592259 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.39171146 |
| 73 | Growth hormone excess (HP:0000845) | 2.39120751 |
| 74 | Flat acetabular roof (HP:0003180) | 2.38863148 |
| 75 | Hyperammonemia (HP:0001987) | 2.38351763 |
| 76 | Fat malabsorption (HP:0002630) | 2.38079119 |
| 77 | Metabolic acidosis (HP:0001942) | 2.36563996 |
| 78 | Pili torti (HP:0003777) | 2.33199969 |
| 79 | Hyperphosphatemia (HP:0002905) | 2.31463185 |
| 80 | Megaloblastic anemia (HP:0001889) | 2.31263869 |
| 81 | Steatorrhea (HP:0002570) | 2.29873655 |
| 82 | Adrenal overactivity (HP:0002717) | 2.26915161 |
| 83 | Renal tubular acidosis (HP:0001947) | 2.23479898 |
| 84 | Cerebral palsy (HP:0100021) | 2.22904565 |
| 85 | Abnormality of vitamin metabolism (HP:0100508) | 2.20688991 |
| 86 | Ketosis (HP:0001946) | 2.18845868 |
| 87 | Posterior subcapsular cataract (HP:0007787) | 2.16728568 |
| 88 | Cupped ribs (HP:0000887) | 2.16425203 |
| 89 | Abnormality of sodium homeostasis (HP:0010931) | 2.16195346 |
| 90 | Hyponatremia (HP:0002902) | 2.14990503 |
| 91 | Axonal loss (HP:0003447) | 2.13594942 |
| 92 | Nephritis (HP:0000123) | 2.11571357 |
| 93 | Myopathic facies (HP:0002058) | 2.11363190 |
| 94 | Abnormal hair laboratory examination (HP:0003328) | 2.10465757 |
| 95 | Late onset (HP:0003584) | 2.08909329 |
| 96 | Hypolipoproteinemia (HP:0010981) | 2.07183746 |
| 97 | Intrahepatic cholestasis (HP:0001406) | 2.04751362 |
| 98 | Abnormality of the costochondral junction (HP:0000919) | 2.03633826 |
| 99 | Subcapsular cataract (HP:0000523) | 2.02259131 |
| 100 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.01832150 |
| 101 | Nausea (HP:0002018) | 2.01256746 |
| 102 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.00722703 |
| 103 | Vomiting (HP:0002013) | 1.98339459 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95438189 |
| 105 | Rickets (HP:0002748) | 1.93161574 |
| 106 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92938150 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 1.92938150 |
| 108 | Hypotension (HP:0002615) | 1.92742295 |
| 109 | Abnormality of carpal bone ossification (HP:0006257) | 1.91681059 |
| 110 | Ankle clonus (HP:0011448) | 1.91286064 |
| 111 | Gastrointestinal dysmotility (HP:0002579) | 1.90856125 |
| 112 | Distal upper limb amyotrophy (HP:0007149) | 1.90413975 |
| 113 | Upper limb amyotrophy (HP:0009129) | 1.90413975 |
| 114 | Decreased circulating renin level (HP:0003351) | 1.90236212 |
| 115 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89631444 |
| 116 | Protuberant abdomen (HP:0001538) | 1.89055313 |
| 117 | Pigmentary retinal degeneration (HP:0001146) | 1.87444590 |
| 118 | Enlarged epiphyses (HP:0010580) | 1.87387448 |
| 119 | Villous atrophy (HP:0011473) | 1.87076241 |
| 120 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.87076241 |
| 121 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86290129 |
| 122 | Pancreatitis (HP:0001733) | 1.86014190 |
| 123 | Syncope (HP:0001279) | 1.85982686 |
| 124 | Eczematoid dermatitis (HP:0000976) | 1.85004502 |
| 125 | Vascular calcification (HP:0004934) | 1.83733096 |
| 126 | Lethargy (HP:0001254) | 1.82379050 |
| 127 | Chronic diarrhea (HP:0002028) | 1.82313766 |
| 128 | Symptomatic seizures (HP:0011145) | 1.81675181 |
| 129 | Abnormal glucose tolerance (HP:0001952) | 1.79959560 |
| 130 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.79855542 |
| 131 | Nephrocalcinosis (HP:0000121) | 1.78689106 |
| 132 | Multiple lipomas (HP:0001012) | 1.77428849 |
| 133 | Abnormal foot bone ossification (HP:0010675) | 1.76696792 |
| 134 | Metaphyseal cupping (HP:0003021) | 1.76594631 |
| 135 | Cardiovascular calcification (HP:0011915) | 1.74422246 |
| 136 | Stridor (HP:0010307) | 1.70785386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.85995892 |
| 2 | WNK3 | 5.23208545 |
| 3 | LMTK2 | 4.75804809 |
| 4 | OXSR1 | 4.73607661 |
| 5 | ACVR1B | 4.73222016 |
| 6 | MST4 | 3.94162715 |
| 7 | FRK | 3.78663377 |
| 8 | MST1R | 3.71092464 |
| 9 | STK39 | 3.14512216 |
| 10 | PRKG2 | 2.89593513 |
| 11 | NME1 | 2.56972258 |
| 12 | MAP2K2 | 2.28732761 |
| 13 | GRK6 | 2.27284881 |
| 14 | TAOK2 | 2.21449669 |
| 15 | TRIB3 | 2.05884411 |
| 16 | RIPK1 | 1.97825420 |
| 17 | EPHA2 | 1.90738034 |
| 18 | EPHB2 | 1.80100242 |
| 19 | STK38L | 1.74466159 |
| 20 | SIK1 | 1.70482791 |
| 21 | MAP3K2 | 1.62554692 |
| 22 | TESK2 | 1.49461562 |
| 23 | PTK6 | 1.41644388 |
| 24 | MAP4K1 | 1.40547944 |
| 25 | PBK | 1.37095599 |
| 26 | MAP3K10 | 1.37029588 |
| 27 | MAP2K6 | 1.32323796 |
| 28 | CDC42BPA | 1.25369104 |
| 29 | MAP3K11 | 1.23190343 |
| 30 | EPHA4 | 1.21683727 |
| 31 | PDK3 | 1.13224443 |
| 32 | PDK4 | 1.13224443 |
| 33 | MET | 1.12783813 |
| 34 | MYLK | 1.09371440 |
| 35 | TESK1 | 1.07460547 |
| 36 | TTK | 1.07369605 |
| 37 | PRKCI | 1.06341579 |
| 38 | BCKDK | 1.04370794 |
| 39 | WNK1 | 1.02977685 |
| 40 | TAOK1 | 1.02179913 |
| 41 | ERN1 | 0.95179332 |
| 42 | KSR2 | 0.93593666 |
| 43 | NUAK1 | 0.93065986 |
| 44 | PTK2 | 0.92235193 |
| 45 | TAOK3 | 0.89208761 |
| 46 | PRPF4B | 0.87010000 |
| 47 | AKT3 | 0.86692936 |
| 48 | SMG1 | 0.83546110 |
| 49 | PDK2 | 0.81939313 |
| 50 | TYK2 | 0.81257391 |
| 51 | NEK1 | 0.80744343 |
| 52 | PIK3CA | 0.80098296 |
| 53 | FGFR3 | 0.77408500 |
| 54 | ICK | 0.77125879 |
| 55 | PRKAA2 | 0.76274389 |
| 56 | STK24 | 0.76042567 |
| 57 | ERBB2 | 0.75456919 |
| 58 | PRKD2 | 0.75142976 |
| 59 | MAP3K8 | 0.73242524 |
| 60 | PDGFRA | 0.72760694 |
| 61 | RIPK4 | 0.70817706 |
| 62 | EPHB1 | 0.70152708 |
| 63 | PAK4 | 0.68882773 |
| 64 | STK10 | 0.68715168 |
| 65 | MAP3K1 | 0.68612508 |
| 66 | MAP3K7 | 0.68343344 |
| 67 | TLK1 | 0.67334688 |
| 68 | LATS1 | 0.65274458 |
| 69 | MAPK15 | 0.64431623 |
| 70 | PRKAA1 | 0.61656363 |
| 71 | FER | 0.59783526 |
| 72 | MAP3K3 | 0.59636403 |
| 73 | MAP2K1 | 0.59363443 |
| 74 | MAPK11 | 0.58857524 |
| 75 | DDR2 | 0.58545484 |
| 76 | MAP3K9 | 0.55628976 |
| 77 | SGK223 | 0.52556042 |
| 78 | SGK494 | 0.52556042 |
| 79 | LRRK2 | 0.52047043 |
| 80 | PAK3 | 0.52015805 |
| 81 | PDPK1 | 0.47880155 |
| 82 | IRAK3 | 0.47530552 |
| 83 | STK38 | 0.46751957 |
| 84 | DYRK1B | 0.46086397 |
| 85 | ABL2 | 0.44880611 |
| 86 | EIF2AK1 | 0.44482466 |
| 87 | BMX | 0.41928376 |
| 88 | PIM2 | 0.41825579 |
| 89 | MARK2 | 0.41334892 |
| 90 | GSK3A | 0.40065844 |
| 91 | EPHA3 | 0.38809756 |
| 92 | RPS6KA2 | 0.38633266 |
| 93 | AURKB | 0.35834269 |
| 94 | ZAP70 | 0.35143076 |
| 95 | MATK | 0.34675434 |
| 96 | CDK19 | 0.33415158 |
| 97 | ERBB4 | 0.33368813 |
| 98 | SGK3 | 0.33145751 |
| 99 | PIK3CG | 0.33047299 |
| 100 | MAP3K12 | 0.32822655 |
| 101 | BRAF | 0.32740435 |
| 102 | SCYL2 | 0.31457297 |
| 103 | DAPK2 | 0.30319983 |
| 104 | MAP3K5 | 0.30271362 |
| 105 | PRKCA | 0.29756716 |
| 106 | NME2 | 0.28906442 |
| 107 | ARAF | 0.28834910 |
| 108 | ROCK1 | 0.28715050 |
| 109 | TNK2 | 0.28298005 |
| 110 | EEF2K | 0.27209453 |
| 111 | NTRK1 | 0.26844940 |
| 112 | SIK2 | 0.26756550 |
| 113 | RET | 0.26232947 |
| 114 | CAMK2G | 0.26141265 |
| 115 | DMPK | 0.24083817 |
| 116 | CSNK1A1 | 0.24073284 |
| 117 | FGFR4 | 0.23895853 |
| 118 | TYRO3 | 0.23788990 |
| 119 | GRK1 | 0.22989105 |
| 120 | PRKD3 | 0.22933289 |
| 121 | PKN2 | 0.22123039 |
| 122 | FYN | 0.21291737 |
| 123 | RPS6KC1 | 0.21143423 |
| 124 | RPS6KL1 | 0.21143423 |
| 125 | PRKACG | 0.21000872 |
| 126 | PAK1 | 0.20898098 |
| 127 | SGK1 | 0.20469024 |
| 128 | PDK1 | 0.19611254 |
| 129 | MELK | 0.19270453 |
| 130 | TBK1 | 0.18566850 |
| 131 | ILK | 0.18086903 |
| 132 | LIMK1 | 0.17276882 |
| 133 | CAMK2D | 0.16969410 |
| 134 | OBSCN | 0.16191629 |
| 135 | PRKCZ | 0.16048814 |
| 136 | STK11 | 0.15886553 |
| 137 | PRKCD | 0.14749439 |
| 138 | AKT2 | 0.14366115 |
| 139 | SRC | 0.13809233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.70350441 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.34433301 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.23128233 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.14762978 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09757714 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.02444111 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.83209431 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.74209310 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.70343128 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.28028045 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22911522 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 2.21022527 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.11435069 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05263892 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.05228039 |
| 16 | Galactose metabolism_Homo sapiens_hsa00052 | 2.05107629 |
| 17 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.02908577 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01455617 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.00953338 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.95562288 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92501971 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89975857 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89153324 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.87866051 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79202550 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.78986447 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76916092 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.74649019 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72303951 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.48531705 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46328942 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.45028239 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39533524 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.37627781 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33337296 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33039087 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.24554635 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23895119 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21807954 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18229364 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17030452 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14166731 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13396186 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.12614060 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99081429 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96269711 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95390813 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92866814 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89476527 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88452968 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86904820 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.86376256 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85377503 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84018789 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80909025 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78130396 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77738334 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75843392 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74758301 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70850695 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70611330 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.69887673 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 0.69107041 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68273394 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66957652 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.58324950 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57788168 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57225100 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57033769 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56407164 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55603135 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55470410 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54280075 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51715257 |
| 75 | Allograft rejection_Homo sapiens_hsa05330 | 0.51285469 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50640385 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50017626 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49496398 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48917121 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48662715 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47696084 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47098383 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.46635168 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45809306 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45397428 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43603609 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43453352 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40486391 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40306159 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39130380 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.39067349 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38739160 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36901606 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36379437 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34288324 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34066627 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.31208155 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29658758 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28751370 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25429729 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24595707 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24448116 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22382650 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.19232669 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19168540 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16914133 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.15902500 |
| 108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.15161436 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.14816562 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14736072 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.13032377 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.12982036 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10759583 |
| 114 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.10393115 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10332680 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08843955 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.07740084 |
| 118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.07603337 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07017521 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06994457 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.06738313 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06434964 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.04342975 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04128162 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.03655364 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.03623313 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03542298 |
| 128 | Adherens junction_Homo sapiens_hsa04520 | 0.02684201 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.00671052 |

